Rockwell Medical appoints Joan Lau, PhD to board as Class II director

ROCKWELL MEDICAL, INC.

Board expands from six to seven; Dr. Lau appointed Class II director, term until 2026 annual meeting.
Dr. Lau receives $45k annual cash retainer (pro-rated), option for 25k shares, and 25k RSUs, vesting Oct 16, 2024.
Dr. Lau is CEO of Spirovant Sciences, partner at Militia Hill Ventures, and serves on Brandywine Realty Trust board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joan Lau, PhD

Class II director

RMTI · ROCKWELL MEDICAL, INC.

Effective: 2023-10-16
Filed: October 17, 2023, 7:59 PM ET

appointed Joan Lau, PhD to the Board as a Class II director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joan Lau, PhD was appointed as Class II director at ROCKWELL MEDICAL, INC..

Action: appointed
Role: Class II director

Exact text from the filing

appointed Joan Lau, PhD to the Board as a Class II director

View on SEC.gov

ROCKWELL MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-109482

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.